Ami Organics Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2120.40

+23.50 (+1.12%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2120.40

+23.50 (+1.12%)
16:02 Dec 20

Quality

39/100
Medium Financial Strength

Valuation

18/100
Expensive Valuation

Technical

65/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	340.61	520.14	616.73	717.47	814.8
Operating Expenses +	260.45	414.96	494.13	588.98	666.69
Raw Material	178.1	282.33	345.85	440.17	468.62
Increase Decrease in Cost	1.4	-9.5	-14.96	-28.48	3.28
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	21.01	41.37	48.84	63.11	71.87
Miscellaneous Expenses	66.76	100.76	114.4	114.18	122.92
Operating Profit	80.16	105.18	122.6	128.49	148.11
Other Income	1.38	2.76	4.32	7.49	14.31
Depreciation	4.19	10.08	12.34	16.06	21.67
Interest	5.62	6.41	2.41	5.94	9.54
Profit before tax and exceptio..	71.73	91.45	112.17	113.99	131.21
Exceptional Items	0	0	0	-32.08	-0.33
PBT	71.73	91.45	112.17	81.9	131.54
Provision for Taxation	17.73	19.5	28.88	33.19	35.14
Net Profit	54	71.95	83.29	48.71	95.75
NET Profit after MI	54	71.95	83.29	42.77	93.18
EPS	17.14	21.03	22.86	11.67	24.73
Operating Profit Margin (%)	23.53	20.22	19.88	17.91	18.18
Net Profit Margin (%)	15.85	13.83	13.51	5.96	11.44

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	36.00	36.00	39.90	39.90	38.90
FII	13.90	12.90	9.00	11.70	7.20
MF	13.10	8.60	3.90	5.40	4.40
Public	30.20	36.30	44.30	40.80	48.00
Others	0.00	0.00	0.00	0.10	0.00
Others	6.80	6.20	2.90	2.10	1.50